The Q4 earnings report for Contineum Therapeutics (NASDAQ:CTNM) was released on Thursday, March 5, 2026 at 04:00 PM.

Here's what investors need to know about the latest announcement.

Earnings

Contineum Therapeutics missed estimated earnings by -13.95%, reporting an EPS of $-0.49 versus an estimate of $-0.43.

Revenue was down $0 from the same period last year.

Overview of Past Earnings

During the previous quarter, the company beat on EPS by $0.06, leading to a 4.46% increase share price change the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Contineum Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.